ANXA1 and neoplasm: Silencing of ANXA1 has been reported to reduce tumour growth in vivo in other studies where ANXA1 knockdown in SUM149 TNBC and HCT116 colorectal cancer cells grown as subcutaneous xenografts have been shown to grow significantly slower than non-silenced cancer cells [34, 36].